Biopharmaceuticals: Approval Trends in 2005 - - BioPharm International

ADVERTISEMENT

Biopharmaceuticals: Approval Trends in 2005


BioPharm International
Volume 19, Issue 8

REFERENCES

1 Walsh G. Biopharmaceutical benchmarks. Nature biotechnol. In press

2 Pavlou AK, Reichert JM. Recombinant protein therapeutics—success rates, market trends and values to 2010. Nature biotechnol. 2004;22:1513-19.

3 Pavlou A, Belsey, M. The therapeutic antibody market to 2008. Eur. J. Pharm. Biopharm. 2005; 59:389-396.

4 http://www.fda.gov/

5 http://www.emea.eu.int/

6 Walsh G. Biopharmaceuticals: approvals and approval trends in 2004. Biopharm Int.2005;18 (5):58-65.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here